Bespoke Extracts (BSPK) Gains from Investment Securities (2017 - 2025)
Bespoke Extracts' (BSPK) quarterly Gains from Investment Securities came in at $1.5 million in Q3 2025, down 1.44% year-on-year from $1.6 million in Q3 2024, and up 6757.08% quarter-over-quarter from $22500.0 in Q2 2025.
Bespoke Extracts (BSPK) Gains from Investment Securities (2017 - 2025) Analysis & Trends
Bespoke Extracts has disclosed Gains from Investment Securities across 9 years of filings, most recently posting $1.5 million for Q3 2025.
- Gains from Investment Securities for Q3 2025 came in at $1.5 million, down 1.44% year-over-year; the trailing twelve-month figure through Sep 2025 was $1.5 million (down 1.44% YoY), and the FY2024 annual result was $1.6 million, up 603.52% from the prior year.
- Gains from Investment Securities came in at $1.5 million for Q3 2025 at Bespoke Extracts, up from $22500.0 in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $32.7 million in Q2 2022 to a low of -$450000.0 in Q4 2024.
- The 5-year median for Gains from Investment Securities is $366803.5 (2023), against an average of $4.1 million.
- Across the five-year window, Gains from Investment Securities sank 209.86% in 2024 and soared 1458.43% in 2025, its largest moves.
- Bespoke Extracts' Gains from Investment Securities stood at $100000.0 in 2021, then slumped by 131.82% to -$31825.0 in 2022, then surged by 1387.06% to $409607.0 in 2023, then tumbled by 209.86% to -$450000.0 in 2024, then jumped by 442.85% to $1.5 million in 2025.
- The last three Gains from Investment Securities figures came in at $1.5 million (Q3 2025), $22500.0 (Q2 2025), and $1.5 million (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn |
| 10 | Bespoke Extracts | - | - | 234,175.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 1.54 Mn |
| Sep 30, 2025 | 1.54 Mn |
| Jun 30, 2025 | 22,500.00 |
| Jun 30, 2025 | 22,500.00 |
| Mar 31, 2025 | 1.54 Mn |
| Mar 31, 2025 | 1.54 Mn |
| Dec 31, 2024 | -450,000.00 |
| Dec 31, 2024 | -450,000.00 |
| Sep 30, 2024 | 1.57 Mn |
| Sep 30, 2024 | 1.57 Mn |
| Jun 30, 2024 | 324,000.00 |
| Jun 30, 2024 | 324,000.00 |
| Mar 31, 2024 | 99,000.00 |
| Mar 31, 2024 | 99,000.00 |
| Dec 31, 2023 | 409,607.00 |
| Dec 31, 2023 | 409,607.00 |
| Sep 30, 2023 | 222,500.00 |
| Sep 30, 2023 | 222,500.00 |
| Jun 30, 2023 | 56,001.00 |
| Jun 30, 2023 | 56,001.00 |